Tandem Diabetes Care announces Q2 2023 results; detailed figures unavailable from excerpt

TANDEM DIABETES CARE INC

2023-Q2 EPS reported -$2.47 revenue$365,300,000

Company issued press release on August 3, 2023 for quarter ended June 30, 2023.
Exhibit 99.1 press release not fully provided; specific revenue or EPS figures are missing.
Filing indicates earnings results were reported but no financial data is extractable from the given text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.